Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

October 2013

Reminder: Synagis for the Upcoming RSV Season 



With respiratory syncytial virus (RSV) season approaching, Harvard Pilgrim would like to remind providers of our policy regarding Synagis (palivizumab), an injection of antibodies used to protect high-risk infants from severe RSV disease. Harvard Pilgrim will be using the same prior authorization and distribution process for Synagis during the 2013–2014 RSV season as we did last season.

Synagis requires prior authorization and should be reserved for children with a history of pre-term birth, chronic lung disease, or congenital heart disease. Typically, the first dose is administered at the beginning of November and the last dose at the beginning of March, in order to provide protection through April.

Clinicians may order Synagis for their Harvard Pilgrim patients by faxing the Synagis Medication Request Form to ICORE Healthcare at (866) 554-2673. If the prior authorization criteria are met, ICORE will ship approval orders directly to clinicians’ offices and will bill Harvard Pilgrim. For updated information, please see the Pharmacy Program page, or call Clinical Pharmacy Services at 
(617) 509-1786.

Email this article to a colleague   

Receive Network Matters by e-mail

Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

Medicare Advantage StrideSM (HMO) Plans Offered in January

Harvard Pilgrim #1 for 10th Year in a Row

Pediatric Dental and Vision Coverage

Harvard Pilgrim Collaborates on New Hampshire Medicaid Program

CLINICIAN CORNER

Specialty Pharmacy Name Change

Prior Authorization for Cinryze

P&T Committee Updates

Fecal Bacteriotherapy Now Covered with Prior Authorization

HEDIS Spotlight: Follow-up Care for Children Taking ADHD Medication

Recognizing Social Phobia in the Primary Care Setting

Reminder: Synagis for the Upcoming RSV Season

OFFICE ASSISTANT

C Codes Now Accepted

Outpatient Fee Schedule Updates

2014 CPT and HCPCS codes

Change in Proration for Inpatient Stays with Partial Eligibility

Reminder: HPHConnect Account Revalidation

PUBLICATION INFORMATION

Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network

Annmarie Dadoly,
Editor

Kristin Edmonston,
Production Coordinator